Search

Your search keyword '"Carter, Lauren"' showing total 1,025 results

Search Constraints

Start Over You searched for: Author "Carter, Lauren" Remove constraint Author: "Carter, Lauren"
1,025 results on '"Carter, Lauren"'

Search Results

2. Precisely patterned nanofibres made from extendable protein multiplexes

3. De novo design of monomeric helical bundles for pH‐controlled membrane lysis

4. Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens

5. De novo design of miniprotein antagonists of cytokine storm inducers

6. Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains

7. De novo design of luciferases using deep learning.

8. Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants

10. Preclinical proof of principle for orally delivered Th17 antagonist miniproteins

11. Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies

12. De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8

13. Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

15. Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals

16. Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial

17. Incorporation of sensing modalities into de novo designed fluorescence-activating proteins

18. Process development of a SARS-CoV-2 nanoparticle vaccine

19. A Digital Library for Increasing Awareness About Living Donor Kidney Transplants: Formative Study.

20. Computational design of closely related proteins that adopt two well-defined but structurally divergent folds

21. Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice

22. Perinatal distress in 1p36 deletion syndrome can mimic hypoxic ischemic encephalopathy

23. Computational design of a synthetic PD-1 agonist

24. Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

25. School Psychology Unified Call for Deeper Understanding, Solidarity, and Action to Eradicate Anti-AAAPI Racism and Violence

26. Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge

28. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

30. Symptom Persistence Relates to Volume and Asymmetry of the Limbic System after Mild Traumatic Brain Injury.

31. De novo protein design by deep network hallucination

33. De novo design of a fluorescence-activating β-barrel.

35. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

36. Massively parallel de novo protein design for targeted therapeutics

37. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

38. Improving genetic testing utilization in a tertiary care neonatal intensive care unit through quality improvement.

39. Quadrivalent influenza nanoparticle vaccines induce broad protection

42. In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19

43. Changes in the spawning distribution and biomass of Atlantic mackerel (Scomber scombrus) in the western Atlantic Ocean over 4 decades

45. Using a Standardized Task to Assess the Quality of Teacher-Child Dyadic Interactions in Preschool

47. Fading Protective Equipment in Treating Self- Injury: Description of a Screening Protocol and Case Report.

48. In vivo selection of synthetic nucleocapsids for tissue targeting

49. Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial

50. An Active-Learning Approach to Fostering Understanding of Research Methods in Large Classes

Catalog

Books, media, physical & digital resources